Used as a key intermediate in the synthesis of antifungal agents, particularly in the development of imidazole-based pharmaceuticals. Its structure supports activity against a range of fungal pathogens by inhibiting ergosterol biosynthesis, an essential component of fungal cell membranes. Commonly employed in research for designing new antimicrobial compounds with improved efficacy and reduced toxicity. Also investigated for potential antiparasitic and anticancer applications due to its ability to interact with biological targets involving cytochrome P450 enzymes.